Cart
sales@molnova.com
Bezafibrate
CAS No. 41859-67-0
Bezafibrate( Benzofibrate | Bezalip | Bezatrol | BM 15075 | Difaterol )
Catalog No. M14429 CAS No. 41859-67-0
Bezafibrate(BM15075) is the first clinically tested dual and pan-PPAR co-agonism.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | 32 | In Stock |
|
| 100MG | 45 | In Stock |
|
| 200MG | 57 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBezafibrate
-
NoteResearch use only, not for human use.
-
Brief DescriptionBezafibrate(BM15075) is the first clinically tested dual and pan-PPAR co-agonism.
-
DescriptionBezafibrate(BM15075) is the first clinically tested dual and pan-PPAR co-agonism.
-
In Vitro——
-
In Vivo——
-
SynonymsBenzofibrate | Bezalip | Bezatrol | BM 15075 | Difaterol
-
PathwayMetabolic Enzyme/Protease
-
TargetPPAR
-
RecptorPPARα
-
Research AreaCardiovascular Disease
-
Indication——
Chemical Information
-
CAS Number41859-67-0
-
Formula Weight361.82
-
Molecular FormulaC19H20ClNO4
-
Purity>98% (HPLC)
-
SolubilityEthanol: 18 mg/mL (49.74 mM); DMSO: 72 mg/mL (198.99 mM)
-
SMILESClC1=CC=C(C(NCCC2=CC=C(OC(C)(C)C(O)=O)C=C2)=O)C=C1
-
Chemical Name2-[4-[2-[(4-chlorobenzoyl)amino]ethyl]phenoxy]-2-methyl-propanoic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Tenenbaum A, et al. Cardiovasc Diabetol. 2005 Sep 16;4:14.
molnova catalog
related products
-
(±)4-HDHA
(±)4-HDHA (4-Hydroxy docosahexaenoic acid) is a PPARγ agonist with anti-inflammatory activity that directly inhibits endothelial cell proliferation and sprouting angiogenesis via PPARγ, which can be used in the study of diabetes.
-
Alliin
Alliin is a garlic organosulfur compound that possesses various pharmacological properties.alliin protected against LPS-induced ALI by activating PPARγ which subsequently inhibited LPS-induced NF-κB activation and inflammatory response.?
-
GW 501516
A potent and subtype-selective PPARδ agonist with Ki of 1.1 nM in human PPARδ binding assay.
